Pritelivir

DB11844InvestigationalSmall molecule

Pritelivir has been used in trials studying the prevention of HSV-2 and Genital Herpes.

Chemical structure of Pritelivir
Formula / weight
C18H18N4O3S2 · 402.49 g/mol (avg)
Code names
AIC-316

Resolves to

Compound
UNII07HQ1TJ4JECAS348086-71-5ChEMBLCHEMBL4069597PubChem491941
Structure
InChIKeyIVZKZONQVYTCKC-UHFFFAOYSA-NSMILESCN(C(=O)CC1=CC=C(C=C1)C1=CC=CC=N1)C1=NC(C)=C(S1)S(N)(=O)=O
Transporters
P08183ABCB1Q9UNQ0ABCG2

What you can answer from here — as of September 12, 2026

2TransportersSubstrate / inhibitor direction, not just membership
Listed above
14Drug interactionsStructured to mechanism, not free text
Sign in
7Clinical trialsPhase, status and sponsor resolved per trial
Sign in
8+ReferencesStructured and connected to the statements they support
Sign in

Which companies are running trials of Pritelivir, in which indications and phases, and which of those programs are still active?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In